Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Conservative surgery after radiotherapy with preoperative doses in the treatment of breast cancer].

Identifieur interne : 000A03 ( France/Analysis ); précédent : 000A02; suivant : 000A04

[Conservative surgery after radiotherapy with preoperative doses in the treatment of breast cancer].

Auteurs : E. Darai [France] ; V. Mosseri ; J P Hamelin ; R J Salmon ; I. Karaitianos ; P. Bataini ; G. Mathieu ; R J Vilcoq ; J C Durand

Source :

RBID : pubmed:1837363

Descripteurs français

English descriptors

Abstract

Radiotherapy as primary treatment is one of the means of increasing the rate of conservative treatment in patients with a breast tumour more than 3 cm in diameter. Between 1980 and 1986, 232 patients were treated in the Curie Institute by irradiation followed by conservative surgery for T2NO or T2N1a tumours wider than 3 cm, which accounted for 66 percent of the cases; 126 of these 232 tumours were located in the upper and outer quadrant. Axillary dissection was combined with tumoral excision in 63 percent of the cases. Conservative surgery was performed in patients who, after preoperative irradiation (50 Gy), had a persistent tumour less than 3 cm in diameter. Tumorectomy was complete in 96 percent of the cases, and the operative specimen was sterilized in 20 percent. The mean follow-up period was 46 months. The overall survival rate was 83 percent at 5 years (91 percent for T2NON1a). No local recurrence was observed in 92 percent of the patients at 3 years and 87 percent at 5 years. Nine percent of these women developed lymphoedema of the upper limb. The cosmetic result was good in 70 percent of the cases, fair in 25 percent and poor in 5 percent. The survival rate being the same with this treatment as with mastectomy, and the local recurrence rate being relatively low (13 percent at 5 years), we feel authorized to suggest that this post-radiotherapy conservative surgery should be used, at least in women with T2NON1a breast cancer.

PubMed: 1837363


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:1837363

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Conservative surgery after radiotherapy with preoperative doses in the treatment of breast cancer].</title>
<author>
<name sortKey="Darai, E" sort="Darai, E" uniqKey="Darai E" first="E" last="Darai">E. Darai</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut Curie, Paris.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
<wicri:orgArea>Institut Curie</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Mosseri, V" sort="Mosseri, V" uniqKey="Mosseri V" first="V" last="Mosseri">V. Mosseri</name>
</author>
<author>
<name sortKey="Hamelin, J P" sort="Hamelin, J P" uniqKey="Hamelin J" first="J P" last="Hamelin">J P Hamelin</name>
</author>
<author>
<name sortKey="Salmon, R J" sort="Salmon, R J" uniqKey="Salmon R" first="R J" last="Salmon">R J Salmon</name>
</author>
<author>
<name sortKey="Karaitianos, I" sort="Karaitianos, I" uniqKey="Karaitianos I" first="I" last="Karaitianos">I. Karaitianos</name>
</author>
<author>
<name sortKey="Bataini, P" sort="Bataini, P" uniqKey="Bataini P" first="P" last="Bataini">P. Bataini</name>
</author>
<author>
<name sortKey="Mathieu, G" sort="Mathieu, G" uniqKey="Mathieu G" first="G" last="Mathieu">G. Mathieu</name>
</author>
<author>
<name sortKey="Vilcoq, R J" sort="Vilcoq, R J" uniqKey="Vilcoq R" first="R J" last="Vilcoq">R J Vilcoq</name>
</author>
<author>
<name sortKey="Durand, J C" sort="Durand, J C" uniqKey="Durand J" first="J C" last="Durand">J C Durand</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1837363</idno>
<idno type="pmid">1837363</idno>
<idno type="wicri:Area/PubMed/Corpus">005A28</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005A28</idno>
<idno type="wicri:Area/PubMed/Curation">005A28</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005A28</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005A28</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005A28</idno>
<idno type="wicri:Area/Ncbi/Merge">002C45</idno>
<idno type="wicri:Area/Ncbi/Curation">002C45</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002C45</idno>
<idno type="wicri:doubleKey">0755-4982:1991:Darai E:conservative:surgery:after</idno>
<idno type="wicri:Area/Main/Merge">00DF89</idno>
<idno type="wicri:Area/Main/Curation">00D477</idno>
<idno type="wicri:Area/Main/Exploration">00D477</idno>
<idno type="wicri:Area/France/Extraction">000A03</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Conservative surgery after radiotherapy with preoperative doses in the treatment of breast cancer].</title>
<author>
<name sortKey="Darai, E" sort="Darai, E" uniqKey="Darai E" first="E" last="Darai">E. Darai</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut Curie, Paris.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
<wicri:orgArea>Institut Curie</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Mosseri, V" sort="Mosseri, V" uniqKey="Mosseri V" first="V" last="Mosseri">V. Mosseri</name>
</author>
<author>
<name sortKey="Hamelin, J P" sort="Hamelin, J P" uniqKey="Hamelin J" first="J P" last="Hamelin">J P Hamelin</name>
</author>
<author>
<name sortKey="Salmon, R J" sort="Salmon, R J" uniqKey="Salmon R" first="R J" last="Salmon">R J Salmon</name>
</author>
<author>
<name sortKey="Karaitianos, I" sort="Karaitianos, I" uniqKey="Karaitianos I" first="I" last="Karaitianos">I. Karaitianos</name>
</author>
<author>
<name sortKey="Bataini, P" sort="Bataini, P" uniqKey="Bataini P" first="P" last="Bataini">P. Bataini</name>
</author>
<author>
<name sortKey="Mathieu, G" sort="Mathieu, G" uniqKey="Mathieu G" first="G" last="Mathieu">G. Mathieu</name>
</author>
<author>
<name sortKey="Vilcoq, R J" sort="Vilcoq, R J" uniqKey="Vilcoq R" first="R J" last="Vilcoq">R J Vilcoq</name>
</author>
<author>
<name sortKey="Durand, J C" sort="Durand, J C" uniqKey="Durand J" first="J C" last="Durand">J C Durand</name>
</author>
</analytic>
<series>
<title level="j">Presse medicale (Paris, France : 1983)</title>
<idno type="ISSN">0755-4982</idno>
<imprint>
<date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Mastectomy, Segmental (adverse effects)</term>
<term>Mastectomy, Segmental (methods)</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Preoperative Care</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mastectomie partielle ()</term>
<term>Mastectomie partielle (effets indésirables)</term>
<term>Récidive tumorale locale</term>
<term>Soins préopératoires</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Mastectomy, Segmental</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Mastectomie partielle</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Mastectomy, Segmental</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Preoperative Care</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mastectomie partielle</term>
<term>Récidive tumorale locale</term>
<term>Soins préopératoires</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Radiotherapy as primary treatment is one of the means of increasing the rate of conservative treatment in patients with a breast tumour more than 3 cm in diameter. Between 1980 and 1986, 232 patients were treated in the Curie Institute by irradiation followed by conservative surgery for T2NO or T2N1a tumours wider than 3 cm, which accounted for 66 percent of the cases; 126 of these 232 tumours were located in the upper and outer quadrant. Axillary dissection was combined with tumoral excision in 63 percent of the cases. Conservative surgery was performed in patients who, after preoperative irradiation (50 Gy), had a persistent tumour less than 3 cm in diameter. Tumorectomy was complete in 96 percent of the cases, and the operative specimen was sterilized in 20 percent. The mean follow-up period was 46 months. The overall survival rate was 83 percent at 5 years (91 percent for T2NON1a). No local recurrence was observed in 92 percent of the patients at 3 years and 87 percent at 5 years. Nine percent of these women developed lymphoedema of the upper limb. The cosmetic result was good in 70 percent of the cases, fair in 25 percent and poor in 5 percent. The survival rate being the same with this treatment as with mastectomy, and the local recurrence rate being relatively low (13 percent at 5 years), we feel authorized to suggest that this post-radiotherapy conservative surgery should be used, at least in women with T2NON1a breast cancer.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Bataini, P" sort="Bataini, P" uniqKey="Bataini P" first="P" last="Bataini">P. Bataini</name>
<name sortKey="Durand, J C" sort="Durand, J C" uniqKey="Durand J" first="J C" last="Durand">J C Durand</name>
<name sortKey="Hamelin, J P" sort="Hamelin, J P" uniqKey="Hamelin J" first="J P" last="Hamelin">J P Hamelin</name>
<name sortKey="Karaitianos, I" sort="Karaitianos, I" uniqKey="Karaitianos I" first="I" last="Karaitianos">I. Karaitianos</name>
<name sortKey="Mathieu, G" sort="Mathieu, G" uniqKey="Mathieu G" first="G" last="Mathieu">G. Mathieu</name>
<name sortKey="Mosseri, V" sort="Mosseri, V" uniqKey="Mosseri V" first="V" last="Mosseri">V. Mosseri</name>
<name sortKey="Salmon, R J" sort="Salmon, R J" uniqKey="Salmon R" first="R J" last="Salmon">R J Salmon</name>
<name sortKey="Vilcoq, R J" sort="Vilcoq, R J" uniqKey="Vilcoq R" first="R J" last="Vilcoq">R J Vilcoq</name>
</noCountry>
<country name="France">
<region name="Île-de-France">
<name sortKey="Darai, E" sort="Darai, E" uniqKey="Darai E" first="E" last="Darai">E. Darai</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A03 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000A03 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:1837363
   |texte=   [Conservative surgery after radiotherapy with preoperative doses in the treatment of breast cancer].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:1837363" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024